Skip to main content

Globus Medical, Inc. (GMED)

NYSE: GMED · IEX Real-Time Price · USD
81.22 0.27 (0.33%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap8.18B
Revenue (ttm)927.90M
Net Income (ttm)184.05M
Shares Out100.45M
EPS (ttm)1.80
PE Ratio45.15
Forward PE35.09
Dividendn/a
Ex-Dividend Daten/a
Volume542,019
Open80.52
Previous Close80.95
Day's Range80.40 - 81.46
52-Week Range48.00 - 84.23
Beta1.08
AnalystsBuy
Price Target85.92 (+5.8%)
Est. Earnings DateOct 27, 2021

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventio...

IndustryHealth Care Equipment & Supplies
IPO DateAug 3, 2012
CEODavid Demski
Employees2,200
Stock ExchangeNYSE
Ticker SymbolGMED
Full Company Profile

Financial Performance

In 2020, Globus Medical's revenue was $789.04 million, an increase of 0.47% compared to the previous year's $785.37 million. Earnings were $102.29 million, a decrease of -34.10%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for Globus Medical stock is "Buy." The 12-month stock price forecast is 85.92, which is an increase of 5.79% from the latest price.

Price Target
$85.92
(5.79% upside)
Analyst Consensus: Buy

News

Here's Why You Should Retain Globus Medical (GMED) for Now

Investors are optimistic about Globus Medical (GMED) owing to domestic growth in the spine business and robust demand for the HEDRON line of products.

4 days ago - Zacks Investment Research

Globus Medical (GMED) Up 4.9% Since Last Earnings Report: Can It Continue?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

Globus Medical (GMED) Gets FDA Nod for Excelsius3D

The receipt of FDA's 510(k) clearance for Globus Medical's (GMED) Excelsius3D is expected to expand the company's presence in the intraoperative imaging system space.

1 month ago - Zacks Investment Research

FDA Approves Globus Medical's Consolidated Imaging System

The FDA has approved Globus Medical Inc's (NYSE:GMED) Excelsius3D, an intelligent intraoperative 3-in-1 imaging system. The imaging platform consolidates 360o cone-beam CT, fluoroscopy, and high-resolut...

1 month ago - Benzinga

Globus Medical Announces FDA 510(k) Clearance for Excelsius3D™

Excelsius3D™ – Intelligent 3-in-1 Intraoperative Imaging System Excelsius3D™ – Intelligent 3-in-1 Intraoperative Imaging System

1 month ago - GlobeNewsWire

Globus Medical (GMED) Q2 Earnings Beat Estimates, 2021 View Up

Pull-through from robotics, contributions from new product introductions and resurgence in the Globus Medical's (GMED) biologics business drove second-quarter growth.

1 month ago - Zacks Investment Research

Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 24.44% and 10.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Globus Medical Reports Second Quarter 2021 Results

AUDUBON, Pa., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2021.

1 month ago - GlobeNewsWire

Why Globus Medical (GMED) Could Beat Earnings Estimates Again

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 month ago - Zacks Investment Research

Is Globus Medical's Robotic Surgery Business a Winner?

It's still early, but things look promising.

1 month ago - The Motley Fool

Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Here is Why Growth Investors Should Buy Globus Medical (GMED) Now

Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

2 months ago - Zacks Investment Research

Globus Medical (GMED) Hits 52-Week High, Can the Run Continue?

Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 months ago - Zacks Investment Research

Here's Why You Should Invest In Globus Medical (GMED) Now

Strong first-quarter performance by the U.S. Spine and Enabling Technologies business contributed to Globus Medical's (GMED) top line.

2 months ago - Zacks Investment Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 months ago - Zacks Investment Research

The Next Nano-X, but With Less Risk?

A look at a new SPAC in the healthcare business with great long-term potential.

Other symbols:AAPLABTBFLYHCAQISRG
2 months ago - The Motley Fool

Globus Medical (GMED) Marks New Milestone for ExcelsiusGPS

Globus Medical's (GMED) ExcelsiusGPS Robotic Navigation system reaches new surgical milestone for spinal procedures.

2 months ago - Zacks Investment Research

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

AUDUBON, Pa., July 16, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2...

2 months ago - GlobeNewsWire

Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS®

Robotic Navigation System helps surgeons increase accuracy, reduce radiation, and save time in OR Robotic Navigation System helps surgeons increase accuracy, reduce radiation, and save time in OR

2 months ago - GlobeNewsWire

3 Unstoppable Stocks to Buy and Hold for Years

They are in industries where the annual growth rate is 10% or better.

Other symbols:DKNGMSFT
2 months ago - The Motley Fool

Globus Medical (GMED) Hits New 52-Week High: What's Driving It?

Investors are optimistic about Globus Medical (GMED) owing to significant trend improvement and the company's focus on product development.

2 months ago - Zacks Investment Research

Why Is Globus Medical (GMED) Down 3.8% Since Last Earnings Report?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

3 months ago - Zacks Investment Research

Globus Medical (GMED) Moves 5.4% Higher: Will This Strength Last?

Globus Medical (GMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

4 months ago - Zacks Investment Research

7 Reddit Stocks With Real Bullish Stories

Take a look at these Reddit stocks that are far from speculative. These seven have strong underlying business fundamentals and can be long-term value creators.

Other symbols:AAPLGMEMCNOKOCGNTSLA
4 months ago - InvestorPlace

Globus Medical (GMED) Q1 Earnings Beat Estimates, Margins Up

Globus Medical's (GMED) first-quarter 2021 revenues improved year over year on strength in Enabling Technologies and U.S. Spine.

4 months ago - Zacks Investment Research